Tru Independence LLC Abbott Laboratories Transaction History

Tru Independence LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $837,645 - $986,028	-7,918 Closed	0 $0
Q1 2021 May 20, 2021	SELL	$108.84 - $128.23 $979 - $1,154	-9 Reduced 0.11%	7,918 $949,000
Q4 2020 Mar 09, 2021	BUY	$105.0 - $114.42 $6,825 - $7,437	65 Added 0.83%	7,927 $867,000
Q3 2020 Nov 19, 2020	SELL	$91.64 - $111.29 $316,158 - $383,950	-3,450 Reduced 30.5%	7,862 $855,000
Q2 2020 Aug 19, 2020	BUY	$76.57 - $98.0 $46,631 - $59,682	609 Added 5.69%	11,312 $1.03 Million
Q4 2019 May 19, 2020	BUY	$78.51 - $87.4 $840,292 - $935,442	10,703 New	10,703 $844,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.